TP53 and COVID-19: As shown in Fig. 7d, COVID-19 PBMCs preferentially expressed TP53 isoforms skipping the ninth exon that contains a stop codon, and thus produced a full-length TP53 with complete C-terminal regions essential for its DNA-binding activity69.